糖尿病患者合并新型冠状病毒感染的研究进展  

Research progress on diabetes patients combined with COVID-19 infection

作　　者：黄仙娜 陈云册 周敏[2] 倪磊 HUANG Xianna;CHEN Yunce;ZHOU Min;NI Lei(Department of Respiratory and Critical Care Medicine,People’s Hospital of Mojiang Hani Autonomous County,Puer 654899,China;Department of Respiratory and Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China)

机构地区：[1]墨江哈尼族自治县人民医院呼吸与危重症医学科,云南普洱654899 [2]上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海200025

出　　处：《内科理论与实践》2024年第1期77-81,共5页Journal of Internal Medicine Concepts & Practice

摘　　要：糖尿病患者不仅是新型冠状病毒(新冠)的易感人群,并且在感染新冠后容易出现免疫失衡、过度炎症反应、多脏器功能损伤等并发症,导致病情更为复杂,危重症的概率显著升高,应引起临床医师重视。本文通过回顾国内外相关文献,总结了新冠导致糖代谢异常的机制,以及糖尿病患者感染新冠的临床特点和血糖管理的原则,以提高对此类患者的临床认知和治疗成功率。Diabetic patients are not only susceptible population to COVID-19 infection,but also prone to develop immune imbalance,excessive inflammatory responses,multi-organ dysfunction,and other complications after infection,resulting in complicated condition and a significantly increased risk of critical illness.Therefore,it requires more attention of clinicians.The article reviews the relevant domestic and international literatures and summarizes the mechanisms of abnormal glucose metabolism induced by COVID-19 infection,clinical characteristics of diabetes patients infected with COVID-19,and the principles of blood glucose management,to improve the clinical understanding and treatment success rate of such patients.

关 键 词：新型冠状病毒 糖尿病 血管紧张素转化酶2 细胞因子风暴 

分 类 号：R511[医药卫生—内科学] R587[医药卫生—临床医学]